Peer-reviewed article
We Know Less Than We Think We Know About Perinatal Outcomes.
Most of what we think we know about survival rates for infants born at 22 or 23 weeks’ gestational age is probably wrong. It is wrong because of some well-recognized but oddly persistent quirks in the ways that outcome data are collected…
Most of what we think we know about survival rates for infants born at 22 or 23 weeks’ gestational age is probably wrong. It is wrong because of some well-recognized but oddly persistent quirks in the ways that outcome data are collected and reported. Here are some of those quirks:These inaccuracies and misrepresentations have real-world effects. They lead to clinical decisions, institutional policies, and national policies in which infants are deemed either viable or nonviable. Infants who are deemed nonviable are, of course, not treated, and the prediction of nonviability becomes a self-fulfilling prophecy. Alternatively, some centers or some countries change their policies, treat nonviable infants, and report better outcomes than are reported in many studies. At some such centers, survival rates for infants born at 22 weeks are >30%.6 Survival rates for infants born at 23 weeks are >50%.The solution to these inaccuracies is easy. There should be a standard way of reporting perinatal outcomes. The denominator should be every fetus that is alive at 20 weeks. Outcomes would then include (1) termination of pregnancy, (2) intrauterine fetal demise, (3) stillbirth (with reports of whether a heartbeat was present at birth), (4) survival, and (5) neurodevelopmental impairment. Such an approach has been recommended by several prominent perinatal epidemiologists.7,8 Such data, if standardized and reported, would avoid the sorts of selection bias reported by Atwell et al4 as well as the other sorts of biases noted above. It would allow us to avoid misinforming parents and allow clinical decisions for premature infants to be based on solid facts.
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
Associations of Physician Perspectives, Personal Choices, and Counseling for Severe Congenital Heart Defects
OBJECTIVE: To assess whether physicians' perspectives of outcomes or personal choices are associated with prenatal counseling for termination of pregnancy (TOP) or perinatal hospice for severe congenital heart defects (CHDs). METHOD:…
Variation in the extent to which patient information leaflets describe potential benefits and harms of trial interventions: a commentary
Clinical trial participants must understand the possible risks and benefits of trial interventions before providing their informed consent to participate. The aim of this commentary is twofold: to summarize the discrepancies in the extent…
Pediatric Gender Medicine—Reply
Third, emerging evidence suggests that modulating glycosylation pathways could offer a novel therapeutic strategy for asthma management.Xie et al 5 proposed that targeting glycan recognition receptors, such as sialic acid-binding…
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.